GoAI
Get started
Jacobio Pharmaceuticals Group Co., Ltd. logo

Jacobio Pharmaceuticals Group Co., Ltd.

1167.HK

HKSEHealthcareBiotechnology

Open in GoAI

Latest quote

HK$5.21

Market data unavailable

Aug 24, 3:18 PM HKT

1167.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Industry
Biotechnology
Sector
Healthcare
Headquarters
CN

Market position

Volume
1.37M
Market cap
4.07B HKD

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
3.65B CNY
P/E (TTM)
-23.99×
P/B (TTM)
4.49×
P/S (TTM)
65.42×
EV / EBITDA
-25.46×
Earnings yield
-3.21%
Free cash flow yield
-4.23%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
78.03%
Operating margin
-317.00%
Net margin
-270.69%
Return on equity
-18.44%
Return on assets
-10.90%
Return on invested capital
-15.15%

Financial health

Debt / equity
0.21×
Current ratio
5.1×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends173%-118%-408%-699%Gross margin, FY2021: 8.40%Gross margin, FY2022: 13.20%Gross margin, FY2023: 5.04%Gross margin, FY2024: 100.00%Gross margin, FY2025: 56.28%Operating margin, FY2021: -209.01%Operating margin, FY2022: -411.72%Operating margin, FY2023: -626.38%Operating margin, FY2024: -120.85%Operating margin, FY2025: -317.76%Net margin, FY2021: -197.10%Net margin, FY2022: -388.38%Net margin, FY2023: -565.36%Net margin, FY2024: -100.00%Net margin, FY2025: -272.73%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 8.40%. Gross margin FY2022 13.20%. Gross margin FY2023 5.04%. Gross margin FY2024 100.00%. Gross margin FY2025 56.28%. Operating margin FY2021 -209.01%. Operating margin FY2022 -411.72%. Operating margin FY2023 -626.38%. Operating margin FY2024 -120.85%. Operating margin FY2025 -317.76%. Net margin FY2021 -197.10%. Net margin FY2022 -388.38%. Net margin FY2023 -565.36%. Net margin FY2024 -100.00%. Net margin FY2025 -272.73%.

Income trends

Revenue

52.14M CNY-66.51%

Operating income

−165.68M CNY+11.95%

Net income

−142.2M CNY+8.67%
Income trends across reported periods211.07M CNY−10.37M CNY−231.8M CNY−453.24M CNYRevenue, FY2021: 152.81M CNYRevenue, FY2022: 95.75M CNYRevenue, FY2023: 63.52M CNYRevenue, FY2024: 155.71M CNYRevenue, FY2025: 52.14M CNYOperating income, FY2021: −319.38M CNYOperating income, FY2022: −394.2M CNYOperating income, FY2023: −397.88M CNYOperating income, FY2024: −188.17M CNYOperating income, FY2025: −165.68M CNYNet income, FY2021: −301.19M CNYNet income, FY2022: −371.86M CNYNet income, FY2023: −359.12M CNYNet income, FY2024: −155.71M CNYNet income, FY2025: −142.2M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 152.81M CNY. Revenue FY2022 95.75M CNY. Revenue FY2023 63.52M CNY. Revenue FY2024 155.71M CNY. Revenue FY2025 52.14M CNY. Operating income FY2021 −319.38M CNY. Operating income FY2022 −394.2M CNY. Operating income FY2023 −397.88M CNY. Operating income FY2024 −188.17M CNY. Operating income FY2025 −165.68M CNY. Net income FY2021 −301.19M CNY. Net income FY2022 −371.86M CNY. Net income FY2023 −359.12M CNY. Net income FY2024 −155.71M CNY. Net income FY2025 −142.2M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue52.14M CNY155.71M CNY63.52M CNY95.75M CNY152.81M CNY
Cost of goods sold22.79M CNY28.69M CNY60.32M CNY83.11M CNY139.98M CNY
Gross profit29.35M CNY155.71M CNY3.2M CNY12.63M CNY12.83M CNY
Research and development165.49M CNY330.18M CNY372.32M CNY445.65M CNY280.84M CNY
Selling, general, and administrative8.43M CNY43.05M CNY46.62M CNY42.55M CNY16.88M CNY
Operating expenses195.03M CNY343.88M CNY401.08M CNY487.37M CNY315.15M CNY
Interest income30.88M CNY40.86M CNY47.07M CNY24.61M CNY18.77M CNY
Interest expense12.6M CNY8.4M CNY8.31M CNY2.27M CNY568K CNY
Depreciation and amortization22.22M CNY10.83M CNY25.08M CNY13.8M CNY10.79M CNY
Operating income−165.68M CNY−188.17M CNY−397.88M CNY−394.2M CNY−319.38M CNY
Net income−142.2M CNY−155.71M CNY−359.12M CNY−371.86M CNY−301.19M CNY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
60%
6 beats, 4 misses, 0 met estimates
Average EPS surprise
-102.49%
10 comparable reports
Latest EPS result
-0.12
Estimate -0.01 · Miss by 999.91%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.09-0.07-0.24-0.4Q1 '23MissQ3 '23BeatQ1 '24BeatQ3 '24BeatQ1 '25MissQ3 '25BeatQ1 '26MissQ3 '26Estimate
Q1 2023, reported Mar 22, 2023: actual -0.362, estimate -0.317, surprise -14.29%, Miss. Q3 2023, reported Aug 30, 2023: actual -0.238, estimate -0.313, surprise +24.14%, Beat. Q1 2024, reported Mar 28, 2024: actual -0.275, estimate -0.297, surprise +7.41%, Beat. Q3 2024, reported Aug 30, 2024: actual -0.236, estimate -0.29, surprise +18.52%, Beat. Q1 2025, reported Mar 19, 2025: actual 0.021, estimate 0.053, surprise -60.00%, Miss. Q3 2025, reported Aug 29, 2025: actual -0.088, estimate -0.186, surprise +52.94%, Beat. Q1 2026, reported Mar 10, 2026: actual -0.122, estimate -0.011, surprise -999.91%, Miss. Q3 2026, reported Aug 24, 2026: actual —, estimate 0.012, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates813.82M545.02M276.23M7.44MQ3 '22No estimateQ1 '23MissQ3 '23BeatQ1 '24BeatQ1 '25MissQ3 '25MissQ1 '26MissQ3 '26Estimate
Q3 2022, reported Aug 23, 2022: actual 64.06M HKD, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 22, 2023: actual 46.48M HKD, estimate 107.9M HKD, surprise -56.92%, Miss. Q3 2023, reported Aug 30, 2023: actual 43.59M HKD, estimate 32.42M HKD, surprise +34.45%, Beat. Q1 2024, reported Mar 28, 2024: actual 25.51M HKD, estimate 21.63M HKD, surprise +17.90%, Beat. Q1 2025, reported Mar 19, 2025: actual 165.73M HKD, estimate 212.87M HKD, surprise -22.15%, Miss. Q3 2025, reported Aug 29, 2025: actual 50.04M HKD, estimate 54.79M HKD, surprise -8.67%, Miss. Q1 2026, reported Mar 10, 2026: actual 8.75M HKD, estimate 135.48M HKD, surprise -93.54%, Miss. Q3 2026, reported Aug 24, 2026: actual —, estimate 754.18M HKD, surprise —, Comparison unavailable.

1167.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$197.1

-4.23%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.74

-3.03%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$222.2

-2.54%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$48.40

-5.10%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.34

-5.26%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$99.35

-2.98%

ETFs holding 1167.HK

Funds reporting this stock among their holdings, ordered by reported position size.

State Street SPDR Portfolio Emerging Markets ETF logoState Street SPDR Portfolio Emerging Markets ETFSPEM
Market value
774.08K
Weight
0.00%
AUM
17.57B USD
Expense ratio
0.07%
Price / 1D
$52.38+0.61%
iShares Core MSCI Emerging Markets ETF logoiShares Core MSCI Emerging Markets ETFIEMG
Market value
763.47K
Weight
0.00%
AUM
160B USD
Expense ratio
0.09%
Price / 1D
$81.57+0.64%
State Street SPDR S&P Emerging Markets Small Cap ETF logoState Street SPDR S&P Emerging Markets Small Cap ETFEWX
Market value
167.66K
Weight
0.02%
AUM
685.65M USD
Expense ratio
0.65%
Price / 1D
$72.22+0.25%
iShares MSCI China Small-Cap ETF logoiShares MSCI China Small-Cap ETFECNS
Market value
118.59K
Weight
0.18%
AUM
66.48M USD
Expense ratio
0.59%
Price / 1D
$29.37+0.89%
iShares MSCI Emerging Markets Small-Cap ETF logoiShares MSCI Emerging Markets Small-Cap ETFEEMS
Market value
59.44K
Weight
0.02%
AUM
375.88M USD
Expense ratio
0.72%
Price / 1D
$74.72-0.20%
State Street SPDR S&P China ETF logoState Street SPDR S&P China ETFGXC
Market value
50.27K
Weight
0.01%
AUM
474.65M USD
Expense ratio
0.59%
Price / 1D
$91.50+0.51%
State Street SPDR Portfolio MSCI Global Stock Market ETF logoState Street SPDR Portfolio MSCI Global Stock Market ETFSPGM
Market value
9.12K
Weight
0.00%
AUM
1.74B USD
Expense ratio
0.09%
Price / 1D
$87.80+0.55%
iShares Core 80/20 Aggressive Allocation ETF logoiShares Core 80/20 Aggressive Allocation ETFAOA
Market value
1.37K
Weight
0.00%
AUM
3.29B USD
Expense ratio
0.19%
Price / 1D
$99.01+0.49%

Continue in GoAI

Research 1167.HK

research.disclaimer